Michael Schwameis
Overview
Explore the profile of Michael Schwameis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Lutnik M, Cacioppo F, Oppenauer J, Lindmayr T, Schutz N, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004781
: In recent years, awareness of sex disparities in atrial fibrillation (AF) and atrial flutter (AFL) has grown, resulting in significant advancements in sex-specific treatment strategies. As these treatment approaches...
2.
Janata K, Lipa A, Merrelaar A, Merrelaar M, Azizi-Semrad U, Herkner H, et al.
Thromb Haemost
. 2025 Feb;
PMID: 39993438
Background: Pulmonary embolism (PE) requires accurate risk assessment. We investigated the prognostic performance of the National Early Warning Score (NEWS) in emergency department patients with PE. Methods: We included patients...
3.
Kienbacher C, Schorgenhofer C, Ruzicka G, Grafeneder J, Hufnagl C, Jilma B, et al.
Sci Rep
. 2025 Jan;
15(1):123.
PMID: 39747939
Allergic reactions and angioedema are important immunologic conditions in acute care settings. Prior data indicate an association between symptom severity and maximum lysis (ML) in thromboelastometry. We aimed to evaluate...
4.
Kienbacher C, Schoergenhofer C, Ruzicka G, Grafeneder J, Hufnagl C, Jilma B, et al.
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102425.
PMID: 38974798
Background: Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. Objectives: We investigated a possible...
5.
Nagler B, Staudinger T, Schellongowski P, Knoebl P, Brock R, Kornfehl A, et al.
J Thromb Haemost
. 2024 Jun;
22(10):2773-2783.
PMID: 38925491
Background: Unfractionated heparin (UFH) is used in most centers for extracorporeal membrane oxygenation (ECMO) anticoagulation. When standard doses do not achieve desired target values, heparin resistance is reported, most commonly...
6.
Gupta S, Lutnik M, Cacioppo F, Lindmayr T, Schuetz N, Tumnitz E, et al.
Diagnostics (Basel)
. 2024 Apr;
14(7).
PMID: 38611612
Background: Computed tomography (CT) could be a suitable method for acute exclusion of left atrial appendage thrombus (LAAT) prior to cardioversion of atrial fibrillation (AF) and atrial flutter (AFL) at...
7.
Mayerhofer T, Joannidis M, Peer A, Perschinka F, Fries D, Mair P, et al.
Thromb Res
. 2024 Mar;
236:161-166.
PMID: 38452448
Methods: This cohort study included adults at two tertiary care centers who required VV ECMO for severe COVID-19-related acute respiratory distress syndrome (CARDS). Patients received center-dependent argatroban or UFH for...
8.
Harenberg J, Gosselin R, Cuker A, Becattini C, Pabinger I, Poli S, et al.
Thromb Haemost
. 2024 Feb;
124(8):770-777.
PMID: 38316416
Background: With the widespread use of direct oral anticoagulants (DOACs), there is an urgent need for a rapid assay to exclude clinically relevant plasma levels. Accurate and rapid determination of...
9.
Gelbenegger G, Buchtele N, Schoergenhofer C, Grafeneder J, Schwameis M, Schellongowski P, et al.
Semin Thromb Hemost
. 2023 Nov;
50(4):569-579.
PMID: 38029783
Anaphylaxis is a life-threatening condition that involves severe cutaneous, respiratory, and cardiovascular symptoms. Disseminated intravascular coagulation (DIC) is an acquired, widespread activation of coagulation that can be caused by infectious...
10.
Brock R, Kornfehl A, Staudinger T, Schellongowski P, Quehenberger P, Schwameis M, et al.
ASAIO J
. 2023 Oct;
70(3):217-223.
PMID: 37875022
During extracorporeal membrane oxygenation (ECMO) blood is exposed to artificial surfaces, resulting in contact activation of the intrinsic coagulation pathway initiated by coagulation factor XII (FXII). Little is known about...